Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,578 JPY | +3.32% | +2.46% | +44.06% |
May. 28 | RevolKa Signs Master Service Agreement with Daiichi Sankyo | CI |
May. 27 | AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients | DJ |
ETFs positioned on Daiichi Sankyo Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
25.16% | 19 M€ | +11.22% | ||
4.18% | 240 M€ | +17.47% | ||
3.32% | 174 M€ | -.--% | - | |
3.32% | 51 M€ | -.--% | - | |
3.24% | 14 M€ | +18.47% | ||
2.78% | 79 M€ | +18.46% | ||
2.69% | 60 M€ | +24.21% | ||
2.19% | 14 M€ | +19.96% | ||
2.13% | 70 M€ | +18.13% | ||
1.96% | 9,760 M€ | +18.72% | ||
1.95% | 4,929 M€ | +18.61% | ||
1.78% | 0 M€ | -.--% | - | |
1.71% | 25 M€ | +16.23% | ||
1.68% | 15,324 M€ | +15.05% | - | |
1.64% | 28,258 M€ | +15.99% | - | |
1.42% | 63,295 M€ | +18.52% | - | |
1.42% | 140,441 M€ | +19.22% | ||
1.42% | 20,360 M€ | +16.70% | - | |
1.35% | 17 M€ | +14.54% | - | |
1.29% | 4 M€ | +19.76% | ||
1.08% | 57 M€ | +19.30% | ||
0.99% | 64,792 M€ | +15.98% | ||
0.69% | 4 M€ | -.--% | - | |
0.68% | 727 M€ | +7.40% | ||
0.44% | 25 M€ | +3.23% | - | |
0.30% | 10 M€ | -3.35% | - | |
0.30% | 36 M€ | +2.36% | - | |
0.25% | 7 M€ | +5.36% | - | |
0.23% | 276 M€ | +11.40% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.06% | 68.01B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 4568 Stock
- Funds and ETFs Daiichi Sankyo Co., Ltd.